The 3rd Rare & Genetic Kidney Disease Drug Development Summit is a premier industry event dedicated to accelerating the development of therapeutic treatments for rare and genetic kidney diseases such as IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), Alport syndrome, polycystic kidney disease (PKD), and more.
This summit b
12-14 September 2023